|Scott Wolchko||President and Chief Executive Officer|
|Ed Dulac||Chief Financial Officer|
|Bob Valamehr||Chief Development Officer|
|Wayne Chu||Senior Vice President, Clinical Development|
|Srikripa Devarakonda||Truist Securities|
|Carolina Ibanez Ventoso||Stifel|
|Nick Abbott||Wells Fargo|
Welcome to the Fate Therapeutics Fourth Quarter 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode. This call is being webcast live on the Investors and Media section on Fate's Web site at fatetherapeutics.com.
As a reminder, today's call is being recorded. I would now like to introduce Scott Wolchko, President and CEO of Fate Therapeutics.